Profile picture

Doctor Yanling He

(United States of America)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

RNA interference therapy targeting hepatic angiotensinogen for the treatment of hypertension and cardiovascular disease: a first-in-human and proof-of-concept study
Presentation
RNA interference therapy targeting hepatic angiotensinogen for the treatment of hypertension and cardiovascular disease: a first-in-human and proof-of-concept study
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources